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Introduction {#sec001}
============

Intellectual disability (ID) is an early-onset neurodevelopmental disorder affecting 1% of the general population \[[@pone.0208324.ref001]\]. ID is characterized by a significant impairment in cognitive ability and adaptive behavior affecting memory, language, problem solving, and visual comprehension, which can lead to impairments in activities of daily living such as self-care and interpersonal communication.

Environmental factors, such as teratogens, infections, malnutrition, and neurological trauma as well as genetic conditions can cause ID. The literature supports a strong genetic etiology for ID, with a varying proportion of cases (ranging from 17% to 50%) being attributable to genetic causes \[[@pone.0208324.ref002]--[@pone.0208324.ref005]\]. Variants in more than 1,000 genes have been connected to ID \[[@pone.0208324.ref006]\]. Support for rare *de novo* variants as a major cause of ID in simplex cases have been reported \[[@pone.0208324.ref007]\]. Microarray and exome sequencing have demonstrated the importance of *de novo* copy number variations (CNVs) and single‐nucleotide variations (SNVs) in ID. While research elucidating chromosomal aberrations, CNVs, autosomal dominant, and X-linked variants as causes for ID has been well established, it was not until recently that studies focusing on autosomal recessive forms of ID (ARID) have gained attention \[[@pone.0208324.ref006],[@pone.0208324.ref008]\]. ARID either presents as the sole clinical feature (nonsyndromic) or with additional features (syndromic), and it is extremely heterogeneous \[[@pone.0208324.ref009],[@pone.0208324.ref010]\]. To date, there are fifty-five genes in the phenotypic series \[PS249500\] for non-syndromic ARID in the Online Mendelian Inheritance in Man (OMIM) database \[[@pone.0208324.ref006]\]. ARID appears to be a common form of ID, an unsolved healthcare problem creating an enormous socioeconomic burden on society, especially in the underdeveloped countries where there is a high rate of consanguinity \[[@pone.0208324.ref008],[@pone.0208324.ref011]\]. To reveal the causative variants in ARID, we performed Whole Exome Sequencing (WES) in 21 families affected by non-syndromic ID; these families either had multiple affected family members or pedigrees suggestive of consanguinity.

Methods {#sec002}
=======

Ethics statement {#sec003}
----------------

This study was approved by the University of Miami Institutional Review (USA), the Marmara University Medical School Ethics Committee (Turkey), and the Ankara University Medical School Ethics Committee (Turkey). A signed informed consent form was obtained from each participant or, in the case of a minor, from the parents.

Subjects {#sec004}
--------

We included families with ID and a pedigree structure suggestive of autosomal recessive inheritance. These were a mix of multiplex families with parental consanguinity (7 families), simplex families with reported parental consanguinity (5 families), or parental origin from a small town (9 families). All families were from Turkey and evaluated at Marmara University Medical School or Ankara University Medical School. All affected children received a thorough physical examination and were evaluated by a pediatrician, geneticist, and neurologist, when available.

Patients with major anomalies, syndrome specific phenotypic features, and specific neurological signs were excluded from the study. Patients with non-specific minor anomalies (e.g., clinodactyly) and neurological signs (e.g., seizures) were not excluded from the classification of non-syndromic ID, as most patients with ID have such findings. DNA was extracted from patient blood samples for genomic analysis.

Whole exome sequencing and bioinformatics analysis {#sec005}
--------------------------------------------------

In 6 families, we performed WES in two affected siblings, and in 15 families, only the probands were sequenced. Agilent SureSelect Human All Exon 50 Mb was used for the capture and HiSeq 2000 was used for the sequencing per our previously published protocol \[[@pone.0208324.ref012]\]. We filtered variants based on minor allele frequency of \<0.005 for recessive and \<0.0005 for dominant using ExAC (<http://exac.broadinstitute.org/>; accessed 08/15/2018) and GnomAD (<http://gnomad.broadinstitute.org/>; accessed 08/15/2018), a genotype quality (GQ) score \>35 for the variant quality, and minimum read depth of ≥ 8. Combined Annotation Dependent Depletion (CADD: <http://cadd.gs.washington.edu/info>), Sorting Intolerant from Tolerant (SIFT: <http://sift.jcvi.org/>) and Mutationtaster (<http://www.mutationtaster.org/>) were used for the *in silico* prediction. ClinVar (<https://www.ncbi.nlm.nih.gov/clinvar/>) and Human Gene Mutation Database (HGMD: <http://www.hgmd.cf.ac.uk/ac/index.php>) were used for the mutation databases. Genomic evolutionary rate profiling (GERP: <http://mendel.stanford.edu/SidowLab/downloads/gerp/index.html>) score was used to determine variant conservation. While autosomal recessive inheritance with both homozygous and compound heterozygous models were chosen during the initial analysis, all inheritance modes were subsequently investigated. Missense, nonsense, splice site, in-frame INDEL and frame-shift INDELs were selected. We searched for variants in genes already implicated in ID. These genes were retrieved from OMIM with query words including "intellectual disability" or "mental retardation" or "microcephaly" or "cognitive impairment" in Clinical Synopsis ([S1 Table](#pone.0208324.s001){ref-type="supplementary-material"}). We used CoNIFER (Copy Number Inference From Exome Reads) \[[@pone.0208324.ref013]\] and XHMM (eXome-Hidden Markov Model) \[[@pone.0208324.ref014]\] to detect Copy Number Variants (CNVs) \[[@pone.0208324.ref015]\]. For the CNV analysis, we evaluated genes in our list. We filtered out common CNVs using our WES controls that consists of \>500 individuals and Database of Genomic Variants (DGV; <http://dgv.tcag.ca/dgv/app/home>). ACMG 2015 Guidelines were used for the variant interpretation \[[@pone.0208324.ref016]\]. Sanger sequencing was used for variant confirmation and co-segregation (dx.doi.org/10.17504/protocols.io.tzxep7n) ([S2 Table](#pone.0208324.s002){ref-type="supplementary-material"}).

For those families without causative variants in known ID genes, we obtained runs of homozygosity (\>2 MB) shared by affected members of each family ([S3 Table](#pone.0208324.s003){ref-type="supplementary-material"}). Only homozygous INDELs, single nucleotide variants, and CNVs mapping to runs of homozygosity were included in the analysis.

Results {#sec006}
=======

On average, 99%, 94% and 89% of the captured regions were covered by 1X, 5X, and 10X reads, respectively. Average read depth was 59X in our cohort.

Known variants associated with intellectual disability {#sec007}
------------------------------------------------------

We identified two variants that have previously been reported to cause ID in two genes ([Table 1](#pone.0208324.t001){ref-type="table"}). In family S223, one male proband (II:1) was homozygous for c.427dupA (p.T143Nfs\*5) in *MCPH1*. In family S25, both affected brothers (II:1 and II:2) were found to be hemizygous for c.459_462delAGAG (p.R153Sfs\*41) in *PQBP1*.

10.1371/journal.pone.0208324.t001

###### Summary of the identified variants in this study.

![](pone.0208324.t001){#pone.0208324.t001g}

  Family ID                         Gene          MIM\#        Associated Syndrome                                                                    MIM\#        Zygosity     NM\#             cDNA                    Protein         Reference                                          ExAC          gnomAD       CADD   GERP RS   Mutation Taster   SIFT   ClinVar   ACMG
  --------------------------------- ------------- ------------ -------------------------------------------------------------------------------------- ------------ ------------ ---------------- ----------------------- --------------- -------------------------------------------------- ------------- ------------ ------ --------- ----------------- ------ --------- ------
  AU10                              *CC2D1A*      610055       Mental retardation, autosomal recessive 3                                              608443       HM           NM_017721.4      c.811delG               p.A271Pfs\*30   This study                                         N/A           N/A          33     5.3699    N/A               N/A    N/A       P
  MR25                              *FAM183A*     N/A          Novel candidate gene                                                                   N/A          HM           NM_001101376.2   c.377G\>A               p.W126\*        This study                                         0.0008695     0.0009992    38     4.07      DC                N/A    N/A       N/A
  MR32                              *TUSC3*       601385       Mental retardation, autosomal recessive 7                                              611093       HM           NM_006765.3      c.793C\>T               p.Q265\*        This study                                         N/A           N/A          46     4.2399    DC                N/A    N/A       P
  S25                               *PQBP1*       300463       Mental retardation, X-linked, Renpenning type                                          309500       HZ           NM_001032383.1   c.459_462delAGAG        p.R153Sfs\*41   Kalscheuer et al 2003 \[[@pone.0208324.ref017]\]   N/A           N/A          35     N/A       N/A               N/A    P         P
  S223                              *MCPH1*       607117       Microcephaly 1, primary, autosomal recessive                                           251200       HM           NM_024596.4      c.427dupA               p.T143Nfs\*5    Trimborn et al.                                    N/A           N/A          28.8   4.21      N/A               N/A    P/LP      P
  2004 \[[@pone.0208324.ref018]\]                                                                                                                                                                                                                                                                                                                                          
  S228                              *WDR62*       613583       Microcephaly 2, primary, autosomal recessive, with or without cortical malformations   604317       HM           NM_001083961.1   c.3406C\>T              p.R1136\*       This study                                         0.000008267   0.00001806   35     0.266     DC                N/A    N/A       P
  S234                              *SLC9A6*      300231       Mental retardation, X-linked syndromic, Christianson type                              300243       HT           NM_006359.2      c.1631+1G\>A            Splice          This study                                         N/A           N/A          28.4   5.0399    DC                N/A    P         LP
  S236                              *ZNF335*      610827       Microcephaly 10, primary, autosomal recessive                                          615095       HT           NM_022095.3      c.808C\>T               p.R270C         This study                                         0.0006979     0.0005315    24.1   3.8199    DC                DM     VUS       VUS
  HT                                NM_022095.3   c.3715C\>A   p.Q1239K                                                                               This study   0.00004253   0.00001629       23.8                    5.03            DC                                                 DM            N/A          VUS                                                 
  S243                              *ASPM*        605481       Microcephaly 5, primary, autosomal recessive                                           608716       HM           NM_018136.4      c.5219_5225delGAGGATA   p.R1740Tfs\*7   This study                                         N/A           N/A          35     N/A       N/A               N/A    N/A       P
  S244                              *RARS*        107820       Leukodystrophy, hypomyelinating, 9                                                     616140       HM           NM_002887.3      c.1588A\>G              p.T530A         This study                                         N/A           N/A          23.6   4.7899    DC                DM     N/A       VUS

**HM:** Homozygous, **HZ:** Hemizygous, **HT:** Heterozygous, **N/A:** Not Available, **DC:** Disease Causing, **DM:** Damaging, **P:** Pathogenic, **LP:** Likely Pathogenic, **VUS:** Variant of Uncertain Significance, **ACMG:** American College of Medical Genetics Guidelines

Novel variants in known genes associated with intellectual disability {#sec008}
---------------------------------------------------------------------

Whole exome sequencing of the probands resulted in identification of seven novel variants in seven genes known to cause ID ([Table 1](#pone.0208324.t001){ref-type="table"} and [S4 Table](#pone.0208324.s004){ref-type="supplementary-material"}). These variants were associated with varying phenotypes ([Table 2](#pone.0208324.t002){ref-type="table"}). Variant segregation was confirmed with Sanger sequencing ([Fig 1](#pone.0208324.g001){ref-type="fig"}). Homozygous variants in *CC2D1A* and *ASPM* led to frameshift mutations. Additionally, homozygous nonsense variants in *TUSC3* and *WDR62* and a heterozygous variant in *SLC9A6* occurring at a splice site were identified. Lastly, a homozygous substitution in *RARS* and two heterozygous variants in *ZNF335* were found. These results are described in more detail in [Table 1](#pone.0208324.t001){ref-type="table"}.

![The electropherograms of the identified variants and pedigrees of the families in this study.\
WT: Wildtype, MUT: Mutant.](pone.0208324.g001){#pone.0208324.g001}

10.1371/journal.pone.0208324.t002

###### Phenotypic features of probands with causative variants.

![](pone.0208324.t002){#pone.0208324.t002g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Family-individual ID   GENE        Simplex/multiplex   Parental consanguinity reported        Sex                                           Age at last exam                                                            Growth                                 Craniofacial                                                                          Cardiovascular                  Abdomen/ GU                                                                    Skeletal                     Skin/hair/\                      Neurologic
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   nails                            
  ---------------------- ----------- ------------------- -------------------------------------- --------------------------------------------- --------------------------------------------------------------------------- -------------------------------------- ------------------------------------------------------------------------------------- ------------------------------- ------------------------------------------------------------------------------ ---------------------------- -------------------------------- -----------------------------------------------------------------------------
  AU10-II:1              *CC2D1A*    Mx                  Y                                      F                                             11y                                                                         Normal height and head circumference   No distinctive findings                                                               N                               N                                                                              N                            N                                ID, autistic spectrum disorder, seizures

  AU10-II:2              F           *8 y*               Normal height and head circumference   No distinctive findings                       N                                                                           N                                      N                                                                                     N                               ID, history of global developmental delay with autistic features                                                                             

  AU10-II:3              F           *5 y*               Normal height and head circumference   No distinctive findings                       N                                                                           N                                      N                                                                                     N                               Developmental delay especially speech delay with autistic features, seizures                                                                 

  MR25-II:1\             *FAM183A*   Mx                  Y                                      M                                             12 y                                                                        Normal height                          Borderline microcephaly, upslanting palpebral fissures,\                              N                               N                                                                              N                            N                                IQ 48\
                                                                                                                                                                                                                                                                 strabismus, retinal pigmentation                                                                                                                                                                                                                                   Autism Spectrum Disorder

  MR25-II:2\             Y           M                   14 m                                   Normal height                                 Upslanting palpebral fissures, L ptosis, blue sclera, ears slightly large   N                                      Recurrent urinary tract infections                                                    N                               N                                                                              Mild developmental delay                                      

  MR32-II:1\             *TUSC3*     Mx                  Y                                      F                                             8.5 y                                                                       Short stature                          Microcephaly, strabismus                                                              N                               N                                                                              N                            N                                ID, agitations

  MR32-II:2\             Y           F                   3.5 y                                  Borderline short stature                      Microcephaly, strabismus                                                    N                                      N                                                                                     N                               N                                                                              Global developmental delay                                    

  S25-II:1               *PQBP1*     Mx                  Y                                      M                                             20 y                                                                        Short stature,\                        Microcephaly, brachycephaly,\                                                         \                               N                                                                              N                            N                                Moderate ID, history of global delay especially in speech
                                                                                                                                                                                                                          lean body build                        long and narrow face,\                                                                Pectus excavatum                                                                                                                                                             
                                                                                                                                                                                                                                                                 short philtrum, cupped ears, broad nasal bridge                                                                                                                                                                                                                    

  S25-II:2               M           10 y                Short stature                          Microcephaly, long face, broad nasal bridge   N                                                                           N                                      N                                                                                     N                               Moderate ID                                                                                                                                  

  S223-II:1\             *MCPH1*     Sx                  N                                      M                                             1.5 m                                                                       Normal height                          Microcephaly, narrow frontal area, long philtrum, big ears                            N                               N                                                                              Simian crease                Seborrheic dermatitis            Cortical atrophy, deep sulci on cranial MRI

  S228-II:1\             *WDR62*     Sx                  Y                                      M                                             1y                                                                          Normal height                          Microcephaly, bilateral epicanthus                                                    N                               N                                                                              N                            N                                Mild global developmental delay

  S234-II:1\             *SLC9A6*    Sx                  Y                                      F                                             3y                                                                          Normal height                          Microcephaly, square jaw, ophthalmoplegia, L ear anomaly, skin tag                    Narrow chest                                                                                                                                                                 global developmental delay

  S236-II:1\             *ZNF335*    Sx                  Y                                      F                                             2 m                                                                         Normal height                          Severe microcephaly, short neck, big ears, high palate, deep philtrum, micrognathia   Peripheral pulmonary stenosis   Bilateral mild pelviectasis                                                    Long 2^nd^ toe               Bilateral single palmar crease   seizures, cranial MRI: corpus callosum agenesis, hydrocephaly, colpocephaly

  S243-II:1\             *ASPM*      Sx                  Y                                      F                                             2 y                                                                         Normal height                          Severe microcephaly, narrow frontal area, big ears                                    N                               N                                                                              N                            N                                Cranial CT: cortical atrophy, deep sulci

  S244-II:1\             *RARS*      Sx                  Y                                      M                                             8 m                                                                         Normal height                          Severe microcephaly, big ears, micrognathia                                                                           Bilateral inguinal hernia                                                      N                            Sandal gap                       Developmental delay,\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    no eye tracking of light or object
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Blank:** limited clinical information, **Sx:** simplex, **Mx:** multiplex, **y:** years, **m:** months, **M:** male, **F:** female, **N:** no abnormal clinical findings

Mutated *FAM183A* as a causative candidate for intellectual disability {#sec009}
----------------------------------------------------------------------

Whole exome sequencing revealed a nonsense variant (c.377G\>A; p.W126\*) in *FAM183A*, a novel candidate gene for ARID. Two siblings, MR25-II:1 and MR25-II:2, were homozygous for the variant, and in the family, the variant segregated in an autosomal recessive fashion ([Fig 1](#pone.0208324.g001){ref-type="fig"}).

Discussion {#sec010}
==========

We have identified causative variants in 10 out of 21 Turkish families with nonsyndromic ARID.

11 families remained unsolved in our cohort ([S1 Fig](#pone.0208324.s007){ref-type="supplementary-material"} and [S5 Table](#pone.0208324.s005){ref-type="supplementary-material"}).

Known variants associated with intellectual disability {#sec011}
------------------------------------------------------

The two families with previously reported causative variants for ID are phenotypically consistent with the previously described findings. Both brothers (II:1 and II:2) in family S25 show findings indicative of Renpenning syndrome \[MIM 309500\], an X-linked condition \[[@pone.0208324.ref017]\]. Zhang et al (2017) discusses the molecular pathogenesis of mutations in *PQBP1*, pointing toward the promotion of ubiquitin-mediated degradation of fragile X mental retardation protein (FMRP) resulting in synaptic dysfunction \[[@pone.0208324.ref019]\]. WES, elucidating the presence of a known causative variant, accompanied with phenotypic data confirmed a diagnosis of Microcephaly 1 in proband S223-II:1 \[[@pone.0208324.ref018]\].

Novel variants in known genes associated with intellectual disability {#sec012}
---------------------------------------------------------------------

*CC2D1A* variants are associated with ARID (MRT3) \[MIM 608443\]. This disorder is characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior which manifest during the developmental period. Analysis in Drosophila links *CC2D1A*, a member of the mammal lethal giant discs (lgd) protein family, to endosomal trafficking of Notch proteins, well known transmembrane receptors that regulate cell fate during development \[[@pone.0208324.ref020]\]. Basel-Vanagaite et al. (2006) reported homozygosity for a protein truncating mutation in *CC2D1A* in affected members of 9 consanguineous Israeli-Arab families with nonsyndromic ID \[[@pone.0208324.ref021]\]. The homozygous deletion at c.811delG (p.A271Pfs\*30) of *CC2D1A* found in family AU10 is the fifth variant associated with ID reported in this gene.

*TUSC3* variants are known to cause Mental Retardation, Autosomal Recessive 7 (MRT7) \[MIM 611093\]. Including the finding reported here, four independent autosomal recessive variants in *TUSC3* are known to cause ARID \[[@pone.0208324.ref022]--[@pone.0208324.ref024]\]. The exact molecular pathogenesis is unknown. One study suggests the involvement of N-glycosylation in higher brain functions \[[@pone.0208324.ref024]\], while another postulates disturbed magnesium levels due to *TUSC3* impairment may play a role in the pathogenesis of intellectual disability \[[@pone.0208324.ref022]\]. This novel nonsense variant at c.793C\>T (p.Q265\*) in *TUSC3* in family MR32 further demonstrates the significance of this gene's association with ARID.

Seventeen variants in numerous domains of *WDR62* have been reported to be associated with Microcephaly 2, primary, autosomal recessive, with or without cortical malformations (MCPH2) \[MIM 604317\] \[[@pone.0208324.ref025]--[@pone.0208324.ref028]\]. Cellular studies indicate that *WDR62* is a crucial protein in enabling spindle poles to position the cytokinetic furrow and prolong neural precursor generation, a process that is uniquely vital to the proper growth of the human cerebral cortex \[[@pone.0208324.ref025]\]. The attributes of the proband, S228-II:1, described in [Table 2](#pone.0208324.t002){ref-type="table"}, are consistent with this phenotype. This novel homozygous nonsense variant in *WDR62*, c.3406C\>T (p.R1136\*) along with the phenotype of the proband further implicate this gene's involvement in ARID.

Variants in *SLC9A6* are associated with Mental retardation, X-linked syndromic (MRXSCH), Christianson type \[MIM 300243\]. *SLC9A6* encodes a monovalent sodium-selective sodium/hydrogen exchanger (NHE) found in the membranes of intracellular organelles such as mitochondria and endosomes; NHEs participate in a wide array of essential cellular processes \[[@pone.0208324.ref029]\]. MRXSCH is characterized by profound ID, epilepsy, ataxia, and microcephaly. The phenotype of the female proband (S234-II:1), described in [Table 2](#pone.0208324.t002){ref-type="table"}, is consistent with the presentation of MRXSCH. Linkage analysis and DNA sequencing of families with MRXSCH have identified multiple variants in the *SLC9A6*, the majority of which are truncating and/or splice mutations \[[@pone.0208324.ref030]--[@pone.0208324.ref034]\]. The novel heterozygous splice-site variant, c.1631+1G\>A in *SLC9A6*, adds to the body of literature on pathogenic splice-site variants reported in this gene.

*ZNF335* mutations are associated with Microcephaly 10, primary, autosomal recessive (MCPH10) \[MIM 615095\]. One homozygous variant in *ZNF335* (S236-II:1), causing both a missense change and a splice site defect, is linked to this syndrome \[[@pone.0208324.ref035]\]. This same study demonstrated that *ZNF335* deficiency causes disrupted neuronal proliferation and differentiation *in vitro* and *in vivo* mouse models \[[@pone.0208324.ref035]\]. Both discovered variants in our study are predicted to be disease causing and are likely to result in a hypomorphic variant of *ZNF335*. This, in combination with the gene's association with MCPH10 and altered neuronal growth *in vitro* and *in vivo*, make it likely that these mutations are the cause of this family's ID.

Variants in *ASPM* are associated with Microcephaly 5, primary, autosomal recessive (MCPH5) \[MIM 608716\]. ASPM has been implicated in the determination of human cerebral cortical size via maintenance of a cleavage plane orientation allowing for symmetric, proliferative division of neuroepithelial cells during brain development \[[@pone.0208324.ref036]\]. Several aberrations in *ASPM* have been reported in the literature with a clear majority resulting in premature termination \[[@pone.0208324.ref037]--[@pone.0208324.ref041]\]. Similarly to previously reported variants, the novel homozygous deletion c.5219_5225delGAGGATA (p.R1740Tfs\*7) found in *ASPM* (S243-II:1) leads to a premature stop codon, suggesting that this variant is involved in ARID.

Lastly, variants in *RARS* are associated with Leukodystrophy, hypomyelinating, 9 (HLD9) \[MIM 616140\]. *RARS* encodes the cytoplasmic arginyl‐tRNA synthetase, an enzyme essential for RNA translation and a key player in myelination, among the subunits of the multisynthase complex \[[@pone.0208324.ref042]\]. Thus, mutations in *RARS* cause a hypomylenating disorder of the central nervous system. Previously identified variants in *RARS* causing the HLD9 phenotype are compound heterozygous mutations \[[@pone.0208324.ref042]\]. In contrast to previously identified variants in *RARS*, the novel variant found in family S244 is a homozygous missense mutation. After exome sequencing and segregation analysis, these mutations are the only variants that segregate with the family's phenotype. Therefore, we propose that this homozygous missense variant has a role in ARID and is the most likely cause of ID this family.

Mutated *FAM183A* as a causative candidate for intellectual disability {#sec013}
----------------------------------------------------------------------

In family, MR 25, there were two siblings with ID, low set ears, and microcephaly along with other correlating phenotypic features ([Table 2](#pone.0208324.t002){ref-type="table"}, [Fig 1](#pone.0208324.g001){ref-type="fig"}). The two affected children are homozygous for a *FAM183A* variant (c.377G\>A; p.W126\*). This variant, found in MR25-II:1 and MR25-II:2, is located in the longest shared homozygous genomic region in these siblings ([S6 Table](#pone.0208324.s006){ref-type="supplementary-material"}). *FAM183A* is expressed in human brain, including the hippocampus, caudate nucleus, and medulla oblongata \[[@pone.0208324.ref043]\]. Five heterozygous large deletions including *FAM183A* are reported in the DECIPHER database, (<https://decipher.sanger.ac.uk/>; accessed 07/08/2018). Three out of five variants are found in patients with intellectual disability, developmental delay, or microcephaly; however, the variants' pathogenicities are not known \[[@pone.0208324.ref044]\].

The pathogenicity models, expression in brain tissue, and validated autosomal recessive segregation of this variant with the phenotype in family MR 25 support a role for this homozygous nonsense variant as contributing to the inheritance of ID. More research, including functional studies, should be done to further support the role of *FAM183A* in the pathogenesis of ID.

In 10 out of 21 families investigated (47.6%) we identified likely disease-causing DNA variants. Although CNVs are important cause of ID, we did not detect any CNV in our cohort. As expected for affected offspring of healthy consanguineous parents, the clear majority of these were autosomal recessive defects. This yield is comparable to other recent investigations in highly consanguineous populations \[[@pone.0208324.ref007],[@pone.0208324.ref045]--[@pone.0208324.ref050]\].

Supporting information {#sec014}
======================

###### List of the genes used for the analysis in our cohort.

The gene list is created by using the command *((((mental retardation\[Clinical Synopsis\]) OR microcephaly\[Clinical Synopsis\]) OR intellectual disability\[Clinical Synopsis\]) OR cognitive impairment\[Clinical Synopsis\]) AND "prefix pound"\[Properties\]* within the web site <https://www.ncbi.nlm.nih.gov/omim> (accessed 10/02/2018). After curation of the gene list, we analyzed single nucleotide variants, INDELs and copy number variants in the gene list. Due to limitation of the next generation sequencing method that we used, we did not analyze the repeat expansions.
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###### Sequences of the primers used for the Sanger sequencing.
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###### Parameters used for detecting homozygous runs by using Enlis software (<https://www.enlis.com/>).
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###### Chromosomal position of the identified variants (hg19).
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###### Phenotypic features of the unsolved probands.
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###### Autozygous regions shared by MR25- II:1 and II:2 (hg19).
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###### Pedigrees of the unsolved families.
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